• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Liver Cancer UK HomepageLiver Cancer UK

Part of the British Liver Trust

  • About us
  • Health professionals
  • Talk to a nurse 0800 652 7330
  • Twitter
  • Liver cancer information
    • Types of liver cancer
      • HCC liver cancer
        • Overview
        • What is HCC?
        • Symptoms
        • Risks and causes
        • Diagnosis
          • Tests
          • Questions for your doctor
        • Treatment
          • Stages
          • Early stage HCC (0-A)
          • Intermediate HCC (stage B)
          • Advanced HCC (stage C)
          • Very advanced (stage D)
          • If your HCC comes back (recurrence)
          • Check-ups
          • Outcomes (prognosis)
        • Living with HCC
      • Bile duct cancer
        • Overview
        • What is bile duct cancer?
        • Symptoms
        • Risks and causes
        • Diagnosis
          • Tests
          • Questions for your doctor
        • Treatment
          • Stages
          • If cancer can be removed
          • If cancer can’t be removed
          • If cancer is advanced or has come back
          • Questions for your doctor
          • Check-ups
          • Outcomes (prognosis)
        • Living with bile duct cancer
      • Rare types of liver cancers
      • Secondary liver cancer
    • Just diagnosed?
    • Types of treatment
      • Surgery
        • Types of surgery
        • Preparing for surgery
        • After surgery
      • Targeted cancer medicines (biological therapies)
      • Chemotherapy
      • Embolization, TACE and TARE or SIRT
      • Ablation
      • Radiotherapy
      • Treatment for symptoms and advanced cancer
      • About clinical trials
    • Risk and causes of liver cancer
    • Liver cancer tests
    • Living with liver cancer
      • Diet and exercise
      • Coping with advanced cancer
      • Mental wellbeing
      • Money matters
      • Support from others
      • Complementary and alternative therapies
      • Patient stories
    • Our booklets and resources
    • Glossary / useful words
  • Support for you
  • How you can help
  • News and blogs
  • Donate
Home » News and Blogs » Volunteers needed for study into hepatitis…
News

Volunteers needed for study into hepatitis C and liver cancer

October 19, 2021

Researchers at Glasgow Caledonian University are looking for people with hepatitis C to take part in a short interview about their experiences of liver cancer screening. This will form part of a study called THRIVE-SVR.

What is the THRIVE-SVR study?

Liver cancer is a common cause of death in patients with hepatitis C. One important reason for this is that liver cancer is usually diagnosed at a late stage, when it is difficult to treat.

However, if liver cancer is diagnosed early (i.e. when the tumour is small) then the odds of survival are much better.

The THRIVE-SVR is a research study sponsored by the Medical Research Foundation. Its aim is to improve early detection of liver cancer in patients with cured hepatitis C. The way researchers are trying to do this is by developing “risk calculators” that will help doctors identify those patients who are most likely to develop liver cancer.

To help us understand the patient perspective, we would really love to talk to people who have first-hand experience of hepatitis C and liver cancer screening.

Who can get involved?

Researchers want to speak to patients who have (or have had in the past) a hepatitis C infection who have been diagnosed with liver cirrhosis. They are especially interested to hear from those who have a history of liver cancer or those who have been offered screening for liver cancer.

What will happen if I agree to take part?

Participants will be invited to take part in an informal Zoom call with two researchers. The call will last about 45 to 60 minutes. They will ask you questions about your experience and attitudes to liver cancer screening.

Reimbursement

All participants will receive a £50 Amazon voucher as compensation for their time.

How to take part

If you would like to take part in the study, please email Hamish from Glasgow Caledonian University at Hamish.Innes@gcu.ac.uk.

More news items
« Liver cancer patient survey findings
Survey reveals that most adults are unaware of what can increase their risk of liver cancer, the fastest growing cause of cancer death in the UK »

Footer

Liver Cancer UK logo
British Liver Trust logo

Quick links


  • Just been diagnosed
  • Living with cancer
  • Hepatocellular carcinoma (HCC)
  • Bile duct cancer

Contact us


Talk to a nurse on our helpline

0800 652 7330

General enquiries:

info@britishlivertrust.org.uk

01425 481 320

© British Liver Trust. All rights reserved. Registered Office: Venta Court, 20 Jewry Street, Winchester, SO23 8FE.
Registered Charity England and Wales 298858, Scotland SC042140. Company Limited by Guarantee Registered in England and Wales, Company No 2227706

Privacy policy | Cookies

Talk to a nurse on our helpline

0800 652 7330

Scroll Up